Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data<\/i><\/p>\n
LEHI, Utah–(BUSINESS WIRE<\/a>)–Owlet<\/a>, Inc. (\u201cOwlet\u201d or the \u201cCompany\u201d) (NYSE: OWLT), the pioneer of smart infant monitoring, today announced a strategic partnership with webAI<\/a>, a leading private AI platform, to accelerate the development of secure, personalized, and data-driven intelligence across the Owlet product ecosystem.<\/p>\n \nThe partnership represents a foundational step in Owlet\u2019s long-term AI strategy, focused on leveraging the Company\u2019s proprietary infant health and sleep data to deliver tailored insights for families while building durable, differentiated platform capabilities over time. By investing in enterprise-grade AI infrastructure, Owlet aims to responsibly unlock the value of its unique, vast infant wellness dataset, enabling increasingly personalized experiences for parents and caregivers.<\/p>\n \n\u201cWe view AI as a long-term platform investment that strengthens Owlet\u2019s competitive position and further empowers parents in the care of their children,\u201d said Jonathan Harris, President and CEO of Owlet. \u201cPartnering with webAI will accelerate our ability to build private, enterprise-grade intelligence directly on our data, an approach that prioritizes security, scalability, and durability. As our dataset continues to grow, we believe this foundation will allow us to deliver increasingly differentiated insights for families around the world.\u201d<\/p>\n Building AI as a Core Platform Capability<\/b><\/p>\n \nOwlet selected webAI<\/a> as a strategic AI partner based on the platform\u2019s deep expertise in private AI systems purpose-built for sensitive-data environments. Trusted by leading consumer health companies, webAI enables companies to train intelligence on proprietary data and operate it on its owned and controlled infrastructure.This approach is designed to ensure data privacy, regulatory alignment, and scalability as Owlet expands its connected hardware and software elements globally.<\/p>\n \nKey elements of the partnership include:<\/p>\n \nBy training AI on its growing base of longitudinal data, Owlet expects insights to become increasingly accurate, personalized, and differentiated over time, reinforcing a data advantage and creating long-term value for its users.<\/p>\n \n\u201cwebAI is a private AI platform designed for organizations working with sensitive, proprietary data just like Owlet,\u201d said David Stout, CEO at webAI. \u201cOwlet has built a trusted platform in infant health with a unique depth of pediatric data, and we\u2019re proud to partner with the Company to unlock specialized intelligence that improves with every interaction, while keeping family data protected.\u201d<\/p>\n Positioning Owlet for Long-Term Value Creation<\/b><\/p>\n \nOwlet views AI as a core platform capability, not a standalone feature, that will increasingly power consumer experiences, insights, and services. The Company believes this disciplined, security-first approach positions Owlet to responsibly harness AI while maintaining trust with both families and stakeholders.<\/p>\n \nTo learn more about Owlet and its line of pediatric smart baby monitoring devices, including the best-selling FDA-cleared Dream Sock\u00ae<\/sup> and prescription pulse oximeter BabySat\u00ae<\/sup>, please visit www.owletcare.com<\/a>.<\/p>\n About Owlet, Inc.<\/b><\/p>\n \nOwlet, Inc. (NYSE: OWLT), a leading pediatric health platform, is the only company in the world to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors, delivering hospital-grade technology directly in the home. Our award-winning pediatric products and innovative software combine clinically tested monitoring systems, an integrated video platform, and a simple, easy-to-use app, providing parents with real-time health insights to stay informed on their child\u2019s well-being, support restful sleep, and provide peace of mind anywhere. Since 2012, more than 2.5 million parents have trusted Owlet to monitor their children’s well-being and sleep. This adoption has fueled one of the largest collections of pediatric health and sleep data in the world, powering innovations that bridge the critical gap between hospital and home. Owlet is driving a new standard in pediatric wellness by pairing advanced medical technology with consumer-friendly design. Our mission is simple yet ambitious: to give every baby and every family the best possible start in life. Learn more at www.owletcare.com<\/a> and follow us on LinkedIn<\/a> and Instagram<\/a> for company news and updates.<\/p>\n About webAI<\/b><\/p>\n \nwebAI is the sovereign enterprise AI platform that brings AI to your data. Built for mission-critical environments, it enables organizations to build and operate private, custom models with complete data sovereignty, real-time performance, and predictable economics. From public sector and defense to healthcare and manufacturing, webAI powers specialized AI that enterprises truly own.<\/p>\n Forward-Looking Statements<\/b><\/p>\n \nThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the \u201cReform Act\u201d). All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, without limitation, statements regarding the Company\u2019s strategic partnership with webAI and the anticipated impacts thereof; the Company\u2019s expectations regarding the development, timing, and performance of AI-enabled features, insights, products, and services across its ecosystem; and the Company\u2019s ability to leverage its data to enhance personalization and user experience while maintaining privacy, security, and regulatory compliance; the Company\u2019s ability to expand availability of its products and services in additional markets; and the Company\u2019s ability to enhance its technology, product ecosystem, and service offerings over time. In some cases, you can identify forward-looking statements by terms such as \u201cestimate,\u201d \u201cmay,\u201d \u201cbelieves,\u201d \u201cplans,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cintends,\u201d \u201cgoal,\u201d \u201cpotential,\u201d \u201ccontinues,\u201d the negation thereof, or similar expressions, although not all forward-looking statements contain these identifying words. Forward-looking statements are based on the Company\u2019s expectations at the time such statements are made, speak only as of the dates they are made, and are susceptible to a number of risks, uncertainties, and other factors. For all such forward-looking statements, the Company claims the protection of the safe harbor for forward-looking statements contained in the Reform Act. The Company\u2019s actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by its forward-looking statements. Many important factors could affect the Company\u2019s future results and cause those results to differ materially from those expressed in or implied by the Company\u2019s forward-looking statements. Such factors include, but are not limited to: (i) the commercial success of Owlet\u2019s products, including any new AI-enabled features, insights, products, or services, and the Company\u2019s ability to support, scale and maintain its products island services, including any subscription or software-enabled offerings; (ii) the Company\u2019s ability to develop, integrate, and deploy AI-enabled capabilities on the expected timeline, or at all, and to achieve the anticipated benefits from the partnership; (iii) the regulatory pathway for Owlet\u2019s products, including submissions to, actions taken by and decisions and responses from regulators, such as the FDA and similar regulators outside of the United States, as well as Owlet\u2019s ability to obtain and maintain regulatory approval or certification for its products and comply with ongoing regulatory requirements; (iv) the Company\u2019s and its partners\u2019 obligations relating to data privacy, security and the exchange and use of health information, and risks of cybersecurity incidents or changes in applicable standards or interpretations; (v) the performance of, and Owlet\u2019s ability to maintain and expand, its relationship with third-party technology, cloud, manufacturing and distribution partners; (vi) Owlet\u2019s competition and the Company\u2019s ability to profitably grow and manage growth; (vii) the ability of Owlet to implement strategic initiatives, reduce costs, grow revenues, develop and launch new products, innovate and enhance existing products, meet customer demands and adapt to changes in consumer preferences and retail trends; (viii) Owlet\u2019s ability to acquire, defend and protect its intellectual property and satisfy regulatory requirements concerning privacy and data protection; (ix) Owlet\u2019s ability to maintain relationships with channel partners, customers, manufacturers and suppliers; (x) impacts from compliance with applicable laws or regulations; (xi) the impact of and disruption to Owlet\u2019s business, financial condition, operations, supply chain and logistics due to economic and other conditions beyond the Company\u2019s control; (xii) adverse impacts from other economic, business, regulatory, competitive or other factors, such as changes in discretionary consumer spending and consumer preferences; and (xiii) other risks and uncertainties set forth in the Company\u2019s other releases, public statements and filings with the U.S. Securities and Exchange Commission (\u201cSEC\u201d), including those identified in the \u201cRisk Factors\u201d section of the Company\u2019s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, and as any such factors may be updated from time to time in the Company\u2019s other filings with the SEC. All such forward-looking statements attributable to the Company or any person acting on the Company\u2019s behalf are expressly qualified in their entirety by the cautionary statements contained or referred to above. Moreover, the Company operates in an evolving environment. New risk factors and uncertainties may emerge from time to time, and factors that the Company currently deems immaterial may become material, and it is impossible for the Company to predict such events or how they may affect Owlet. Except as required by law, the Company assumes no obligation to update any forward-looking statements after the date of this press release, whether because of new information, future events or otherwise, although Owlet may do so from time to time. The Company does not endorse any projections regarding future performance that may be made by third parties.<\/p>\n View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260203759621\/en\/<\/a><\/span><\/p>\n Owlet Media Contact: Owlet Investor Contact:\n
<\/p>\n
\n<\/b>
pr@owletcare.com
\n<\/a><\/p>\n
\n<\/b>
ir@owletcare.com<\/a><\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20260203759621\/en\/2709516\/3\/Owlet_Logo_%282%29.jpg\"){kind=logo}
<\/td>\n<\/tr>\n